We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$80.3M
AUM Growth
+$6.68M
Cap. Flow
-$15.7M
Cap. Flow %
-19.56%
Top 10 Hldgs %
78.33%
Holding
71
New
23
Increased
2
Reduced
8
Closed
18

Top Buys

Rank Stock Value
1
NVAX icon
Novavax
NVAX
+$5.6M
2
VERI icon
Veritone
VERI
+$5.09M
3
TELL
Tellurian Inc.
TELL
+$4.54M
4
NTBL
Notable Labs, Ltd. Ordinary Shares
NTBL
+$4.36M
5
ATXS
Astria Therapeutics
ATXS
+$4.12M

Top Sells

Rank Stock Value
1
ADC icon
Agree Realty
ADC
+$5.36M
2
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
+$3.23M
3
AKBA icon
Akebia Therapeutics
AKBA
+$3.12M
4
MGNX icon
MacroGenics
MGNX
+$2.45M
5
NVTA
Invitae Corporation
NVTA
+$2.13M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Communication Services 15.54%
3 Energy 6.49%
4 Technology 5.56%
5 Consumer Staples 2.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DARE icon
51
Dare Bioscience
DARE
$17.4M
– –
-39,305
Closed -$395K
EPIX
52
DELISTED
ESSA Pharma
EPIX
– –
-57,338
Closed -$219K
LAND
53
Gladstone Land Corp
LAND
$365M
– –
-74,336
Closed -$898K
MGNX icon
54
MacroGenics
MGNX
$233M
– –
-97,505
Closed -$2.45M
SNES icon
55
SenesTech
SNES
$6.74M
– –
-11
Closed -$262K
VRDN icon
56
Viridian Therapeutics
VRDN
$2.2B
– –
-6,147
Closed -$646K
CDMO
57
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
– –
-591,991
Closed -$1.73M
NVTA
58
DELISTED
Invitae Corporation
NVTA
– –
-453,358
Closed -$2.13M
AMPE
59
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
– –
-341
Closed -$348K
SRRA
60
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-4,738
Closed -$392K
ZSAN
61
DELISTED
Zosano Pharma Corporation
ZSAN
– –
-10,703
Closed -$1.89M
RESN
62
DELISTED
Resonant Inc.
RESN
– –
-83,746
Closed -$267K
UUUU.WS
63
DELISTED
Energy Fuels Inc.
UUUU.WS
$0 ﹤0.01%
277,777
– –
SGYP
64
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
– –
-1,767,858
Closed -$3.23M
IVTY
65
DELISTED
Invuity, Inc
IVTY
– –
-78,411
Closed -$302K
CVM.WS
66
DELISTED
Cel-Sci Corp Series S
CVM.WS
– –
-750,000
Closed –
1 2
3

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q2 2018 Portfolio in Review

As of Q2 2018, CVI Holdings held 71 positions worth $80.3M, up 9.1% from $73.7M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

CVI Holdings withdrew a net $15.7M in Q2 2018, closing 18 positions and reducing 8 holdings. Its most notable exit was Agree Realty, an estimated $5.36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Communication Services and Energy.

Against the trend, CVI Holdings opened a new position in Novavax worth $4.44M.

  • CVI Holdings's largest Q2 2018 buy was Novavax: 165,780 shares worth $4.44M.
  • CVI Holdings added most to Eros Media World PLC in Q2 2018, an estimated $1.76M increase.
  • CVI Holdings's biggest Q2 2018 reduction was SCYNEXIS, cutting an estimated $1.59M.
  • CVI Holdings fully exited Agree Realty in Q2 2018, selling an estimated $5.36M.
  • CVI Holdings's ten largest holdings make up 78% of its $80.3M portfolio in Q2 2018.
  • CVI Holdings opened 23 new positions and closed 18 in Q2 2018.
  • CVI Holdings's portfolio value rose 9.1% quarter-over-quarter to $80.3M.

Based on CVI Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.